00967nam0-2200313 --450 991049335300332120210913083021.0978-88-572-4370-220210913d2020----kmuy0itay5050 baitaengITa a 001yyAlmo Collegio Borromeoa cura di Alberto LolliMilanoSkira20202 v.ill.30 cm1.: La residenza della bellezza2.: Di luce e ombra / fotografie di Marco MorandottiAlmo Collegio BorromeoStoriaUniversità e collegiItaliaPaviaStoria728.820945291Lolli,AlbertoMorandotti,MarcoITUNINAREICATUNIMARCBK9910493353003321ARCH C 1302/1636/2021FARBCARCH C 1302/2637/2021FARBCFARBCAlmo Collegio Borromeo1867435UNINA04922nam 22011413u 450 991045586880332120210111221640.00-309-50374-4(CKB)111069351130742(EBL)3375300(SSID)ssj0000106797(PQKBManifestationID)11138488(PQKBTitleCode)TC0000106797(PQKBWorkID)10132373(PQKB)10978189(MiAaPQ)EBC3375300(EXLCZ)9911106935113074220170301d2002|||| u|| |engur|n|---|||||txtccrAssessment of the CDC Anthrax Vaccine Safety and Efficacy Research Program[electronic resource]Washington National Academies Press20021 online resource (179 p.)Description based upon print version of record.0-309-08626-4 ""Front Matter""; ""Preface""; ""Reviewers""; ""Contents""; ""Figures, Tables, and Boxes""; ""Abbreviations and Acronyms""; ""Executive Summary""; ""1 Introduction""; ""2 Background""; ""3 The CDC Anthrax Vaccine Research Plan""; ""4 Proposed Studies on the Efficacy of the Anthrax Vaccine""; ""5 Proposed Studies on the Safety of the Anthrax Vaccine""; ""6 Proposed Studies on the Acceptability of the Anthrax Vaccine""; ""7 Summary Assessment of the CDC Anthrax Vaccine Research Plan""; ""Appendix A Biographical Sketches""; ""Appendix B Information-Gathering Meeting Agendas""""Appendix C Anthrax Vaccine Safety & Efficacy Research Plan""""Appendix D Food and Drug Administration Final Rule: New Drug and Biological Drug Products; Evidence Needed to Demonstrate Effectiveness of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible""; ""Appendix E Department of Defense Memorandum: Reintroduction of the Anthrax Vaccine Immunization Program""; ""Appendix F Institute of Medicine: CDC Anthrax Vaccine Safety & Efficacy Research Program. Interim Report Findings and Recommendations1""""Appendix G Institute of Medicine: The Anthrax Vaccine: Is It Safe? Does It Work? Findings and Recommendations1""Anthrax -- VaccinationPublic healthAnthraxVaccinationResearchUnited StatesBacterial VaccinesEvaluation Studies as TopicHealth Care Evaluation MechanismsQuality of Health CareBacillaceae InfectionsInvestigative TechniquesVaccinesHealth Services AdministrationGram-Positive Bacterial InfectionsBacterial InfectionsHealth Care Quality, Access, and EvaluationHealth CareAnalytical, Diagnostic and Therapeutic Techniques and EquipmentBiological ProductsComplex MixturesBacterial Infections and MycosesChemicals and DrugsDiseasesProgram EvaluationDrug EvaluationAnthraxAnthrax VaccinesPublic HealthHILCCHealth & Biological SciencesHILCCCommunicable DiseasesHILCCElectronic books.Anthrax -- Vaccination.Public health.AnthraxVaccinationResearchBacterial VaccinesEvaluation Studies as TopicHealth Care Evaluation MechanismsQuality of Health CareBacillaceae InfectionsInvestigative TechniquesVaccinesHealth Services AdministrationGram-Positive Bacterial InfectionsBacterial InfectionsHealth Care Quality, Access, and EvaluationHealth CareAnalytical, Diagnostic and Therapeutic Techniques and EquipmentBiological ProductsComplex MixturesBacterial Infections and MycosesChemicals and DrugsDiseasesProgram EvaluationDrug EvaluationAnthraxAnthrax VaccinesPublic HealthHealth & Biological SciencesCommunicable Diseases615Staff Institute of Medicine893223Institute of Medicine (U.S.) Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program.AU-PeELAU-PeELAU-PeELBOOK9910455868803321Assessment of the CDC Anthrax Vaccine Safety and Efficacy Research Program2093399UNINA